Elastic Security Achieves the Only Perfect Score in the 2026 AV-Comparatives Endpoint Prevention and Response Test

Elastic Security received AV-Comparatives' highest Certified Leader distinction in its 2026 Endpoint Prevention and Response test, recording the only perfect protection result among tested products. Elastic achieved 100% Active Response and 100% Passive Response scores while posting the lowest modeled operational footprint, reinforcing the competitiveness of its endpoint-security offering.

Analysis

The test result can improve Elastic Security's credibility in enterprise endpoint evaluations, but it is unlikely to move near-term revenue without evidence that the product is displacing incumbent platforms. The relevant KPI is security net expansion and new-logo contribution, not benchmark performance: endpoint is a crowded budget category dominated by CrowdStrike (CRWD), Microsoft (MSFT) and SentinelOne (S). A lower operational footprint could be commercially relevant for resource-constrained IT teams because it reduces deployment friction and total cost of ownership, potentially making Elastic more competitive in bundled SIEM-plus-endpoint consolidations.

The more important second-order opportunity is cross-sell. If endpoint credibility increases Elastic's attach rate into its existing observability/search installed base, incremental security ARR should carry attractive margins because the company already owns much of the data platform and sales relationship. Conversely, competitors with endpoint-first franchises retain major advantages in installed telemetry, managed-service ecosystems and renewal inertia; a third-party score alone does not establish sustained detection efficacy or enterprise-scale win rates.

Near term, this is primarily a sentiment and sales-enablement input rather than an earnings catalyst. Over the next 1-3 months, watch for security pipeline commentary, endpoint references in customer wins, and any increase in security-specific RPO/remaining performance obligation disclosure. The thesis is falsified if management does not identify security as a source of bookings acceleration or if incremental security sales require elevated discounting, pressuring subscription gross margin; absent those signals, there is no reason to underwrite multiple expansion versus CRWD.

Contrarian view: the market may correctly treat this as low-materiality marketing news. AV testing rewards prevention/response performance under defined conditions, whereas enterprise purchasing increasingly centers on platform consolidation, identity telemetry, cloud workload coverage, SOC workflow and switching costs. Elastic's upside is therefore underappreciated only if this result converts into measurable bundle attach and reduces customer acquisition cost—not simply if it generates favorable security-industry coverage.

Key Decisions for Investors

• Maintain ESTC as a watch-list long rather than initiate on this announcement. Upgrade to a 3-6 month tactical long only if the next earnings call shows security bookings or security ARR accelerating relative to company-wide subscription growth; target a 10-15% relative rerating versus IGV if cross-sell evidence emerges.
• For a cleaner expression of potential platform-consolidation share gains, consider a small long ESTC / short S pair over the next 1-3 months, sized modestly given limited disclosed endpoint revenue. Exit if SentinelOne reaccelerates ARR/net retention or Elastic's security pipeline commentary remains qualitative.
• Do not chase CRWD weakness solely on this development. CrowdStrike's earnings risk is driven more by module retention, platform spend and pricing than by a single endpoint benchmark; use any broad endpoint-security selloff to assess CRWD valuation versus its recurring-revenue durability.
• Set an event alert for Elastic's next quarterly results: actionable confirmation would be security-led deal wins, higher multi-solution attach, or stable/improving subscription gross margin. A guidance cut, weaker billings, or evidence of endpoint discounting invalidates the bullish cross-sell thesis.